Announced
Completed
Financials
Tags
Iceland
Pharmaceuticals
drug discovery
Acquisition
Majority
Private
Cross Border
Friendly
Single Bidder
Completed
Synopsis
Coloplast, a manufacturer of medical devices, completed the acquisition of Kerecis, a biotechnology company pioneering the use of fish skin, for $1.3bn. “I am very excited to welcome the Kerecis team into the Coloplast family. Both Coloplast and Kerecis are on a mission to help many more patients in need of advanced wound treatment, and I look forward to continuing the growth and profitability journey, as we build a truly global wound care franchise together,” Kristian Villumsen, Coloplast President and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.